Skip to main content
HR 2863 107th Congress House

Cell Development Research Act of 2001

Official title: To direct the Secretary of Health and Human Services to establish and maintain a panel to provide expert scientific recommendations in the field of cell development.

Introduced: December 5, 2001 See on congress.gov
Health Cell biology and embryologyClinical trialsCloningCytology
More subjectsShow fewer subjects
Department of Health and Human ServicesDrug approvalsDrugsExecutive reorganizationFederal advisory bodiesGene therapyGenetic researchGovernment Operations and PoliticsHuman geneticsMedical geneticsMedical researchMedical testsPharmaceutical researchScience, Technology, Communications
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 17, 2001
Referred to the Subcommittee on Health.
Sep 6, 2001
Referred to the House Committee on Energy and Commerce.
Sep 6, 2001
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action September 17, 2001

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service
Cell Development Research Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to provide for the establishment and maintenance of a single panel in the Food and Drug Administration to: (1) provide expert scientific advice and recommendations in the field of cell development, including advice and recommendations regarding any clinical investigation of a drug developed as a result of research in the field of embryology and any approval for marketing of such a drug; and (2) make policy recommendations with the goal of promoting research in the field of cell development. Prohibits the panel making recommendations regarding the practice of fertility medicine.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 2
D
McGovern, James P.
Massachusetts · May 22, 2002
 D
Schakowsky, Janice D.
Illinois · Dec 5, 2001
KLECZKA, GERALD
· Sep 13, 2001
SANDLIN, MAX
· Sep 13, 2001
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2863: Cell Development Research Act of 2001. 107th Congress. Open America. https://openamerica.io/bill/107-HR-2863/
MLA
"H.R. 2863: Cell Development Research Act of 2001." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-2863/.
Bluebook (legal)
H.R. 2863, 107th Cong. (2026), https://openamerica.io/bill/107-HR-2863/.
Markdown link
[H.R. 2863: Cell Development Research Act of 2001](https://openamerica.io/bill/107-HR-2863/)
Report a problem